Picture of Sorrento Therapeutics logo

SRNE — Sorrento Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Sorrento Reports Promising Results With Universal Chimeric MRNA COVID Vaccine

March 20 (Reuters) - Sorrento Therapeutics Inc  SRNE.O :
    * SORRENTO REPORTS PROMISING RESULTS WITH UNIVERSAL CHIMERIC
MRNA
COVID-19 VACCINE
    * SORRENTO THERAPEUTICS - INTENDS TO DEVELOP AND SEEK EUA
APPROVAL
OF THIS NEXT-GENERATION MRNA VACCINE IN MEXICO AND OTHER
DEVELOPING COUNTRIES
    * VACCINE ELICITS POTENT NEUTRALIZING ANTIBODIES AND
PROTECTION
AGAINST OMICRON (BA.1 AND BA.2) AND DELTA VARIANTS

Source text for Eikon:  ID:nGNXbQfph4 
Further company coverage:  SRNE.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Sorrento Therapeutics

See all news